CAYLEN CABLE: Open Payments
NPI 1881160794 · GREENSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 9 payments from 6 companies in 2025. Trend: 2023 $895 · 2024 $880 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $16 |
Products named: KISQALI, TEFLARO, DALVANCE, VOQUEZNA, Kerendia, Tymlos, BEVESPI AEROSPHERE.
Industry payments across IN — which companies pay providers there.
